Full-Time

Next Generation Sales Engine

Data Scientist

Confirmed live in the last 24 hours

Zoetis

Zoetis

5,001-10,000 employees

Develops and sells animal health products

No salary listed

Mid, Senior

Parsippany-Troy Hills, NJ, USA

In Person

Category
Data Science
Data & Analytics
Required Skills
Microsoft Azure
Python
Data Science
R
Data Structures & Algorithms
SQL
Machine Learning
Tableau
Natural Language Processing (NLP)
Business Analytics
Requirements
  • Masters from an accredited college/university in Computer Science, Statistics, Mathematics, with a minimum of two years of relevant experience 2 years of professional experience working as a Data Scientist
  • Microsoft Azure – Machine Learning Studio, HD Insight
  • Proficiency in analysis – “R” packages, programming languages (Python)
  • Tableau Certification – Developer / Administrator
  • Strong knowledge in the following fields: machine learning, data visualization, statistical modeling, data mining and information retrieval
  • Strong analytical mind and in-depth understanding of key business drivers
  • Strong interpersonal skills and excellent written and verbal communication skills
  • Fluency in English required
  • Experience with command-line scripting, data structures and algorithms and ability to work with SQL Server, processing large amounts of data in a cloud environment
Responsibilities
  • Understand and use statistical predictive models such as regression and time series models to identify trends, make forecasts and provide projected figures
  • Perform machine learning, natural language, such as classification, collaborative filtering, association rules, sentiment analysis and topic modeling
  • Develop new Dashboards and Self-Serve capabilities that proactively enable the Field Force, positioning data to leaders for Sales optimization and Performance Management
  • Drive initiatives focused on Big Data and Advanced Business Analytics, in diverse domains such as product sales, marketing research, pricing; communicate results and educate others through reports and presentations

Zoetis focuses on animal health by discovering, developing, manufacturing, and selling a variety of medicines and vaccines for animals. Their products cater to both veterinarians and pet owners, as well as livestock producers. The company operates in two main areas: companion animals, which includes dogs, cats, and horses, and livestock, which covers cattle, swine, poultry, and fish. In the companion animal segment, Zoetis offers vaccines, treatments for parasites, and skin care products. For livestock, they provide vaccines, anti-infectives, and medicated feed additives. Zoetis stands out from its competitors through its commitment to research and development, investing significantly to create new and enhanced products. With a strong global presence, they market their products in over 100 countries, ensuring a wide reach. Their goal is to improve animal health and well-being while generating revenue through diverse product offerings across various markets.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Parsippany-Troy Hills, New Jersey

Founded

1952

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing pet telemedicine boosts Zoetis' companion animal segment.
  • Precision livestock farming enhances productivity, benefiting Zoetis' livestock segment.
  • mRNA vaccine technology offers new product development opportunities for Zoetis.

What critics are saying

  • Alternative proteins may reduce demand for traditional livestock products, impacting Zoetis.
  • Generic competition pressures Zoetis' pricing and market share.
  • Regulatory scrutiny on antibiotics could limit Zoetis' anti-infective market.

What makes Zoetis unique

  • Zoetis leads in animal health with a diverse portfolio of medicines and vaccines.
  • Strong global presence in over 100 countries enhances Zoetis' market reach.
  • Focus on innovation and R&D drives Zoetis' competitive edge in animal health.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Company News

PharmaData
Jun 6th, 2025
Zoetis Highlights Environmental and Social Impact in 2024 Update

Zoetis, a global leader in animal health, has released its 2024 Sustainability Progress Update, titled "Advancing Sustainability in Animal Health for a Better Future," marking the fifth consecutive year the company has reported on its purpose-driven sustainability strategy.

Vettimes
Apr 24th, 2025
Zoetis to host VN parasitology CPD event

Zoetis to host VN parasitology CPD event.

PYMNTS
Apr 17th, 2025
How To Manage Risks When Employees Use Ai Secretly For Work

Employees who use generative artificial intelligence tools in the workplace without company approval or oversight — a practice known as “bring your own AI’ or BYOAI — could introduce risks into the enterprise, according to MIT researchers. “Make no mistake, I’m not talking theory here,” said Nick van der Meulen, a research scientist at MIT’s [] The post How to Manage Risks When Employees Use AI Secretly for Work appeared first on PYMNTS.com.

MarketBeat
Mar 11th, 2025
Clare Market Investments LLC Makes New $670,000 Investment in Zoetis Inc. (NYSE:ZTS)

Clare Market Investments LLC makes new $670,000 investment in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Mar 10th, 2025
Raymond James Financial Inc. Makes New $196.65 Million Investment in Zoetis Inc. (NYSE:ZTS)

Raymond James Financial Inc. makes new $196.65 million investment in Zoetis Inc. (NYSE:ZTS).